× Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our privacy policy



meta|IO

Living evidence synthesis
about Immuno-Oncology drugs

Member of the meta|Evidence galaxy

Pathology  

Latest studies

Modul Cohort 4, 2023

metastatic/advanced - colorectal cancer (mCRC)

atezolizumab plus cometinib

CONTACT-03, 2023

metastatic/advanced RCC (mRCC) - 2nd line (L2)

atezolizumab plus cabozantinib

CheckMate 9DW, 2024

metastatic/advanced hepatocellular cancer (mHCC)

nivolumab plus ipilimumab plus SoC

CARES-310, 2023

metastatic/advanced hepatocellular cancer (mHCC)

VEGF(R) inhibitor

Treatments

447
treatments 		  367
studies 		  1263
references
This project is supported by H2020 Qualitop, an EU-funded project, Hospices Civils de Lyon and CNRS UMR5558 LBBE.
     

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons